Transplantation of Lymphocytes Co-Cultured with Human Cord Blood-Derived Multipotent Stem Cells Attenuates Inflammasome Activity in Ischemic Stroke

References

• Collaborators GBDS. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–458. doi:10.1016/S1474-4422(19)30034-130871944
   PubMed Web of Science ®Google Scholar
• Rajsic S, Gothe H, Borba HH, et al. Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ. 2019;20(1):107–134. doi:10.1007/s10198-018-0984-029909569
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Goldstein LB, Higashida RT, et al. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013;44(8):2361–2375. doi:10.1161/STR.0b013e31829734f223697546
   PubMed Web of Science ®Google Scholar
• Hankey GJ. Stroke. Lancet. 2017;389(10069):641–654. doi:10.1016/S0140-6736(16)30962-X27637676
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Bath PM. Stroke research in 2018: extended time windows, refined benefit, and lifestyle prevention targets. Lancet Neurol. 2019;18(1):2–3. doi:10.1016/S1474-4422(18)30457-530563678
   PubMed Web of Science ®Google Scholar
• Lambertsen KL, Finsen B, Clausen BH. Post-stroke inflammation-target or tool for therapy? Acta Neuropathol. 2019;137(5):693–714. doi:10.1007/s00401-018-1930-z30483945
   PubMed Web of Science ®Google Scholar
• Zierath D, Schulze J, Kunze A, et al. The immunologic profile of adoptively transferred lymphocytes influences stroke outcome of recipients. J Neuroimmunol. 2013;263(1–2):28–34. doi:10.1016/j.jneuroim.2013.07.01423948692
   PubMed Web of Science ®Google Scholar
• Offner H, Hurn PD. A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Trans Stroke Res. 2012;3(3):324–330. doi:10.1007/s12975-012-0187-4
   Web of Science ®Google Scholar
• Ducruet AF, Connolly ES Jr. Targeting lymphocytes in ischemic stroke. World Neurosur. 2011;76(3–4):212–214. doi:10.1016/j.wneu.2011.06.060
   Web of Science ®Google Scholar
• Liesz A, Zhou W, Mracsko E, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134(Pt 3):704–720. doi:10.1093/brain/awr00821354973
   PubMed Web of Science ®Google Scholar
• Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15(8):946–950. doi:10.1038/nm.199919648929
   PubMed Web of Science ®Google Scholar
• Liesz A, Hu X, Kleinschnitz C, Offner H. Functional role of regulatory lymphocytes in stroke: facts and controversies. Stroke. 2015;46(5):1422–1430. doi:10.1161/STROKEAHA.114.00860825791715
   PubMed Web of Science ®Google Scholar
• Ren X, Akiyoshi K, Dziennis S, et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci. 2011;31(23):8556–8563. doi:10.1523/JNEUROSCI.1623-11.201121653859
   PubMed Web of Science ®Google Scholar
• Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15(2):192–199. doi:10.1038/nm.192719169263
   PubMed Web of Science ®Google Scholar
• Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30(5):636–645. doi:10.1016/j.immuni.2009.04.01019464986
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Stephens LA, Anderton SM. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol. 2005;175(5):3025–3032. doi:10.4049/jimmunol.175.5.302516116190
   PubMed Web of Science ®Google Scholar
• Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, Borlongan CV. Stem cell transplantation for neuroprotection in stroke. Brain Sci. 2013;3(1):239–261. doi:10.3390/brainsci301023924147217
   PubMedGoogle Scholar
• Kozlowska H, Jablonka J, Janowski M, Jurga M, Kossut M, Domanska-Janik K. Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells Dev. 2007;16(3):481–488. doi:10.1089/scd.2007.999317610378
   PubMed Web of Science ®Google Scholar
• Liu K, Guo L, Zhou Z, Pan M, Yan C. Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke. Microvasc Res. 2019;123:74–80. doi:10.1016/j.mvr.2019.01.00130611747
   PubMed Web of Science ®Google Scholar
• Chang YC, Shyu WC, Lin SZ, Li H. Regenerative therapy for stroke. Cell Trans. 2007;16(2):171–181. doi:10.3727/000000007783464669
   Web of Science ®Google Scholar
• Haas S, Weidner N, Winkler J. Adult stem cell therapy in stroke. Curr Opin Neurol. 2005;18(1):59–64. doi:10.1097/00019052-200502000-0001215655404
   PubMed Web of Science ®Google Scholar
• Sanberg PR, Willing AE, Garbuzova-Davis S, et al. Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci. 2005;1049:67–83. doi:10.1196/annals.1334.00815965108
   PubMed Web of Science ®Google Scholar
• Koh SH, Kim KS, Choi MR, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 2008;1229:233–248. doi:10.1016/j.brainres.2008.06.08718634757
   PubMed Web of Science ®Google Scholar
• Kim SW, Han H, Chae GT, et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger’s disease and ischemic limb disease animal model. Stem Cells. 2006;24(6):1620–1626. doi:10.1634/stemcells.2005-036516497946
   PubMed Web of Science ®Google Scholar
• He Y, Li H, Zhang F, et al. Immunotherapeutic effects of lymphocytes co-cultured with human cord blood-derived multipotent stem cells transplantation on APP/PS1 mice. Behav Brain Res. 2016;315:94–102. doi:10.1016/j.bbr.2016.08.02527528555
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang H, Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res. 2006;312(13):2454–2464. doi:10.1016/j.yexcr.2006.04.00816716296
   PubMed Web of Science ®Google Scholar
• Vendrame M, Cassady J, Newcomb J, et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004;35(10):2390–2395. doi:10.1161/01.STR.0000141681.06735.9b15322304
   PubMed Web of Science ®Google Scholar
• Lewis ID. Clinical and experimental uses of umbilical cord blood. Int Med J. 2002;32(12):601–609. doi:10.1046/j.1445-5994.2002.00276.x
   Google Scholar
• Erices AA, Allers CI, Conget PA, Rojas CV, Minguell JJ. Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Trans. 2003;12(6):555–561. doi:10.3727/000000003108747154
   Web of Science ®Google Scholar
• Park DH, Borlongan CV, Willing AE, et al. Human umbilical cord blood cell grafts for brain ischemia. Cell Trans. 2009;18(9):985–998. doi:10.3727/096368909X471279
   PubMed Web of Science ®Google Scholar
• Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304(5667):104–107. doi:10.1126/science.109393315064419
   PubMed Web of Science ®Google Scholar
• Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472–476. doi:10.1161/01.STR.17.3.4723715945
   PubMed Web of Science ®Google Scholar
• Bouet V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol. 2007;203(2):555–567. doi:10.1016/j.expneurol.2006.09.00617067578
   PubMed Web of Science ®Google Scholar
• Zhao J, Mou Y, Bernstock JD, et al. Synthetic oligodeoxynucleotides containing multiple telemeric ttaggg motifs suppress inflammasome activity in macrophages subjected to oxygen and glucose deprivation and reduce ischemic brain injury in stroke-prone spontaneously hypertensive rats. PLoS One. 2015;10(10):e0140772. doi:10.1371/journal.pone.014077226473731
   PubMed Web of Science ®Google Scholar
• Liesz A, Kleinschnitz C. Regulatory T cells in post-stroke immune homeostasis. Trans Stroke Res. 2016;7(4):313–321. doi:10.1007/s12975-016-0465-7
   Web of Science ®Google Scholar
• Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev. 2006;212:60–73. doi:10.1111/j.0105-2896.2006.00415.x16903906
   PubMed Web of Science ®Google Scholar
• Zhao Y, Jiang Z, Zhao T, et al. Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med. 2012;10:3. doi:10.1186/1741-7015-10-322233865
   PubMed Web of Science ®Google Scholar
• He B, Li X, Yu H, Zhou Z. Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus. J Diabetes. 2015;7(6):762–773. doi:10.1111/1753-0407.1228625799887
   PubMed Web of Science ®Google Scholar
• Walsh JG, Muruve DA, Power C. Inflammasomes in the CNS. Nat Rev Neuroscience. 2014;15(2):84–97. doi:10.1038/nrn363824399084
   PubMed Web of Science ®Google Scholar
• Mamik MK, Power C. Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts. Brain. 2017;140(9):2273–2285. doi:10.1093/brain/awx13329050380
   PubMed Web of Science ®Google Scholar
• Fann DY, Lee SY, Manzanero S, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 2013;4:e790. doi:10.1038/cddis.2013.32624008734
   PubMed Web of Science ®Google Scholar
• Fann DY, Santro T, Manzanero S, et al. Intermittent fasting attenuates inflammasome activity in ischemic stroke. Exp Neurol. 2014;257:114–119. doi:10.1016/j.expneurol.2014.04.01724805069
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Unsicker K. ERK and cell death: ERK1/2 in neuronal death. FEBS J. 2010;277(1):22–29. doi:10.1111/j.1742-4658.2009.07367.x19843173
   PubMed Web of Science ®Google Scholar
• Sagulenko V, Vitak N, Vajjhala PR, Vince JE, Stacey KJ. Caspase-1 is an apical caspase leading to caspase-3 cleavage in the AIM2 inflammasome response, independent of caspase-8. J Mol Biol. 2018;430(2):238–247. doi:10.1016/j.jmb.2017.10.02829100888
   PubMed Web of Science ®Google Scholar
• Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009;40(5):e331–339. doi:10.1161/STROKEAHA.108.53163219182083
   PubMed Web of Science ®Google Scholar